FDA Adverse Event Injury Summary report: N

ENDO GIA* II 45-3.5 DLU

MDR report key: 3904218 · Received June 2, 2014

Report

Report Number
2647580-2014-00405
Event Type
Injury
Date Received
June 2, 2014
Report Date
May 8, 2014
Manufacturer
COVIDIEN, FORMERLY USSC PUERTO RICO
Product Code
GDW
PMA / PMN Number
K900129
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

PROCEDURE TYPE: GASTRIC BYPASS. ACCORDING TO THE REPORTER: THERE WAS POSTOPERATIVE BLEEDING. THERE WAS NO UNANTICIPATED TISSUE LOSS. THERE WAS NO TISSUE DAMAGE. NO REOPERATION WAS NEEDED. NO TRANSFUSION WAS NEEDED. NO REINFORCEMENT MATERIAL USED. THERE WAS EXTENDED HOSPITAL STAY. SUBSEQUENT FOLLOW UP: FOLLOWING SURGERY HOW WAS THE BLEEDING RECOGNIZED: BLOOD IN FECES, MELENA SYMPTOMS, DECREASED HGB. WERE THERE ANY PROBLEMS WITH BLEEDING NOTED AT THE TIME OF THE ORIGINAL SURGERY: THE SURGEONS HAS BEEN PLACING MORE CLIPS ON THE STAPLE ROW THAT THEY USE TO DO AND FEELS THAT IS BLEEDING MORE FROM THE RELOADS. WHERE WAS THE BLEEDING NOTED TO BE COMING FROM: (GASTROJEJUNOSTOMY (LINEAR FORMED OR CIRCULAR FORMED?) JEJUJEUNOSTOMY: IN ALL CASES BLEEDING CAME FROM GASTROJEJUJUNOSTOMY MADE WITH RELOAD 030422. WHAT WAS DONE TO CONTROL THE BLEEDING OR HOW WAS THE BLEEDING TREATED: BY SEWING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
322221 ENDO GIA* II 45-3.5 DLU DISPOSABLE SURGICAL STAPLING DEVICE GDW COVIDIEN, FORMERLY USSC PUERTO RICO

Patients

Seq Age Sex Outcome Treatment
1 Other| R EGIA ULTRA UNIVERSAL XL STAPLER, EGIAUXL, K083519